Dolutegravir as First- or Second-line Treatment for Children With HIV: 240-Week Follow-up of the ODYSSEY Randomized Trial.
Saved in:
| Title: | Dolutegravir as First- or Second-line Treatment for Children With HIV: 240-Week Follow-up of the ODYSSEY Randomized Trial. |
|---|---|
| Authors: | Mujuru, Hilda Angela1 (AUTHOR), White, Ellen2 (AUTHOR), Kekitiinwa, Adeodata R3 (AUTHOR), Lugemwa, Abbas4 (AUTHOR), Kityo, Cissy5 (AUTHOR), Violari, Avy6 (AUTHOR), Ahimbisibwe, Grace Miriam7 (AUTHOR), Variava, Ebrahim6 (AUTHOR), Archary, Moherndran8 (AUTHOR), Cotton, Mark9 (AUTHOR) |
| Source: | Open Forum Infectious Diseases. May2026, Vol. 13 Issue 5, p1-9. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 194264488 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Dolutegravir as First- or Second-line Treatment for Children With HIV: 240-Week Follow-up of the ODYSSEY Randomized Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Mujuru%2C+Hilda+Angela%22">Mujuru, Hilda Angela</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22White%2C+Ellen%22">White, Ellen</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kekitiinwa%2C+Adeodata+R%22">Kekitiinwa, Adeodata R</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lugemwa%2C+Abbas%22">Lugemwa, Abbas</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kityo%2C+Cissy%22">Kityo, Cissy</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Violari%2C+Avy%22">Violari, Avy</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ahimbisibwe%2C+Grace+Miriam%22">Ahimbisibwe, Grace Miriam</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Variava%2C+Ebrahim%22">Variava, Ebrahim</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Archary%2C+Moherndran%22">Archary, Moherndran</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cotton%2C+Mark%22">Cotton, Mark</searchLink><relatesTo>9</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Open+Forum+Infectious+Diseases%22">Open Forum Infectious Diseases</searchLink>. May2026, Vol. 13 Issue 5, p1-9. 9p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=194264488 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/ofid/ofag266 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 9 StartPage: 1 Titles: – TitleFull: Dolutegravir as First- or Second-line Treatment for Children With HIV: 240-Week Follow-up of the ODYSSEY Randomized Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mujuru, Hilda Angela – PersonEntity: Name: NameFull: White, Ellen – PersonEntity: Name: NameFull: Kekitiinwa, Adeodata R – PersonEntity: Name: NameFull: Lugemwa, Abbas – PersonEntity: Name: NameFull: Kityo, Cissy – PersonEntity: Name: NameFull: Violari, Avy – PersonEntity: Name: NameFull: Ahimbisibwe, Grace Miriam – PersonEntity: Name: NameFull: Variava, Ebrahim – PersonEntity: Name: NameFull: Archary, Moherndran – PersonEntity: Name: NameFull: Cotton, Mark IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: May2026 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 23288957 Numbering: – Type: volume Value: 13 – Type: issue Value: 5 Titles: – TitleFull: Open Forum Infectious Diseases Type: main |
| ResultId | 1 |